Literature DB >> 33452976

Changes in the Lipid Peroxidation-Antioxidant Protection System in Women with Ovarian Hyperandrogenism at Different Periods of Reproductive Age.

L I Kolesnikova1, O V Krusko2, L V Belenkaya1, L F Sholokhov1, L A Grebenkina1, N A Kurashova1, S I Kolesnikov1.   

Abstract

We studied changes in LPO processes and antioxidant protection system in women with ovarian hyperandrogenism at various periods of reproductive age 18-45 years. An age-related decrease in total antioxidant activity and accumulation of secondary LPO products, ketodiens and coupled trienes, were found; these changes were accompanied by an increase in the level of superoxide dismutase and a decrease in the concentrations of reduced glutathione, α-tocopherol, and retinol. Women of early reproductive age (18-35 years) with hyperandrogenism were characterized by increased content of oxidized glutathione accompanied by a decrease in the level of α-tocopherol and retinol in comparison with the control group. In women of late reproductive age (35-45 years) with hyperandrogenism, increased superoxide dismutase activity in comparison with the control group was revealed.

Entities:  

Keywords:  antioxidants; hyperandrogenism; lipid peroxidation; polycystic ovary syndrome; reproductive age

Year:  2021        PMID: 33452976     DOI: 10.1007/s10517-021-05057-y

Source DB:  PubMed          Journal:  Bull Exp Biol Med        ISSN: 0007-4888            Impact factor:   0.804


  6 in total

1.  Activity of LPO Processes in Women with Polycystic Ovarian Syndrome and Infertility.

Authors:  L I Kolesnikova; S I Kolesnikov; M A Darenskaya; L A Grebenkina; O A Nikitina; L M Lazareva; L V Suturina; I N Danusevich; E B Druzhinina; A A Semendyaev
Journal:  Bull Exp Biol Med       Date:  2017-01-14       Impact factor: 0.804

2.  Integral indicator of oxidative stress in human blood.

Authors:  L I Kolesnikova; N V Semyonova; L A Grebenkina; M A Darenskaya; L V Suturina; S V Gnusina
Journal:  Bull Exp Biol Med       Date:  2014-10-24       Impact factor: 0.804

Review 3.  Criteria, phenotypes and prevalence of polycystic ovary syndrome.

Authors:  Liliia V Belenkaia; Lyudmila M Lazareva; Walidah Walker; Daria V Lizneva; Larisa V Suturina
Journal:  Minerva Ginecol       Date:  2019-06

Review 4.  Genetics of polycystic ovary syndrome.

Authors:  Kateryna Mykhalchenko; Daria Lizneva; Tatiana Trofimova; Walidah Walker; Larisa Suturina; Michael P Diamond; Ricardo Azziz
Journal:  Expert Rev Mol Diagn       Date:  2017-06-19       Impact factor: 5.225

Review 5.  The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report.

Authors:  Ricardo Azziz; Enrico Carmina; Didier Dewailly; Evanthia Diamanti-Kandarakis; Héctor F Escobar-Morreale; Walter Futterweit; Onno E Janssen; Richard S Legro; Robert J Norman; Ann E Taylor; Selma F Witchel
Journal:  Fertil Steril       Date:  2008-10-23       Impact factor: 7.329

6.  Decreased total antioxidant status and increased oxidative stress in women with polycystic ovary syndrome may contribute to the risk of cardiovascular disease.

Authors:  Veysel Fenkci; Semin Fenkci; Mehmet Yilmazer; Mustafa Serteser
Journal:  Fertil Steril       Date:  2003-07       Impact factor: 7.329

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.